What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
Giovanni Barosi focuses on Internal medicine, Myelofibrosis, Surgery, Gastroenterology and Essential thrombocythemia.
His Internal medicine research integrates issues from Immunology, Oncology and Pathology.
His Myelofibrosis study integrates concerns from other disciplines, such as Myeloid, Leukemia, Anemia and Transplantation.
In general Surgery study, his work on Discontinuation often relates to the realm of Nominal group technique, thereby connecting several areas of interest.
Giovanni Barosi has researched Gastroenterology in several fields, including CD34, Cancer, Venous thrombosis and Histology.
His Essential thrombocythemia research includes elements of Hazard ratio and Confidence interval.
His most cited work include:
- JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. (1114 citations)
- New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment. (843 citations)
- Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. (737 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Myelofibrosis, Gastroenterology, Surgery and Polycythemia vera are his primary areas of study.
His Internal medicine study frequently intersects with other fields, such as Oncology.
His work deals with themes such as Myeloid and Anemia, which intersect with Myelofibrosis.
His research investigates the connection with Gastroenterology and areas like Adverse effect which intersect with concerns in Discontinuation.
Giovanni Barosi interconnects Disease, Pediatrics, Splenectomy and Risk factor in the investigation of issues within Surgery.
His study in Polycythemia vera is interdisciplinary in nature, drawing from both Phlebotomy, Hematocrit and Intensive care medicine.
He most often published in these fields:
- Internal medicine (57.09%)
- Myelofibrosis (53.98%)
- Gastroenterology (21.45%)
What were the highlights of his more recent work (between 2015-2021)?
- Myelofibrosis (53.98%)
- Internal medicine (57.09%)
- Cancer research (10.73%)
In recent papers he was focusing on the following fields of study:
Giovanni Barosi spends much of his time researching Myelofibrosis, Internal medicine, Cancer research, Bone marrow and Polycythemia vera.
His Myelofibrosis study is associated with Pathology.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Oncology.
The various areas that Giovanni Barosi examines in his Bone marrow study include Fibronectin, Hematopoietic stem cell transplantation and Leukemia.
His studies deal with areas such as Phlebotomy and Disease as well as Polycythemia vera.
His biological study spans a wide range of topics, including Thrombosis, Myeloproliferative neoplasm, Hematology and Gene expression profiling.
Between 2015 and 2021, his most popular works were:
- Philadelphia chromosome-negative classical myeloproliferative neoplasms: Revised management recommendations from European LeukemiaNet (185 citations)
- MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis. (158 citations)
- Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease (38 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
The scientist’s investigation covers issues in Internal medicine, Polycythemia vera, Myelofibrosis, Essential thrombocythemia and Myeloproliferative neoplasm.
His Internal medicine study frequently draws connections to adjacent fields such as Oncology.
Giovanni Barosi works mostly in the field of Polycythemia vera, limiting it down to topics relating to Anemia and, in certain cases, Phlebotomy.
His study looks at the relationship between Myelofibrosis and topics such as Young adult, which overlap with Mutation, IDH1, Constitutional symptoms and Predictive value of tests.
His study explores the link between Essential thrombocythemia and topics such as Hematology that cross with problems in Molecular genetics, Myeloproliferative Disorders and Jak2v617f mutation.
His work investigates the relationship between Disease and topics such as Surgery that intersect with problems in Quality of life.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
